Understanding how regulatory T cells keep the immune system in balance
Deciphering the specificity and molecular mechanisms of regulatory T cells using novel approaches
This research looks at how regulatory T cells recognize and quiet harmful immune responses to help people with autoimmune diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11360590 on NIH RePORTER |
What this research studies
From a patient perspective, researchers are using advanced lab tools and imaging to watch regulatory T cells and learn how they stop other immune cells from attacking the body. They plan to follow molecular signals and how T cell receptors remove antigen from antigen-presenting cells to turn off dangerous immune responses. The team combines high-resolution microscopy and molecular studies, and may use both animal models and human immune samples to trace these mechanisms. The goal is to uncover practical ways to boost or mimic these cells to reduce autoimmunity over time.
Who could benefit from this research
Good fit: Ideal candidates would be adults affected by autoimmune diseases or healthy adult volunteers willing to donate blood or tissue samples for research.
Not a fit: People without autoimmune conditions or those seeking immediate clinical treatment are unlikely to receive direct benefit from this basic laboratory-focused research.
Why it matters
Potential benefit: If successful, this work could lead to therapies that boost or mimic regulatory T cells to prevent or treat autoimmune diseases.
How similar studies have performed: Prior laboratory studies, including preliminary work by the PI, suggest antigen-specific actions by regulatory T cells, but the detailed molecular mechanisms remain novel and under active exploration.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Akkaya, Billur — Ohio State University
- Study coordinator: Akkaya, Billur
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.